Concurrent chemoradiotherapy using paclitaxel plus cisplatin in the treatment of elderly patients with esophageal cancer.
about
Definitive concurrent chemoradiotherapy with S-1 and cisplatin in elderly esophageal squamous cell carcinoma patients.Comparative study of cisplatin-based definitive concurrent chemoradiotherapy with S-1 versus paclitaxel for unresectable locally advanced esophageal squamous cell carcinomaLong-term results of definitive concurrent chemoradiotherapy using S-1 in the treatment of geriatric patients with esophageal cancer.Long-term results of definitive concurrent chemoradiotherapy using paclitaxel plus oxaliplatin in unresectable locally advanced esophageal cancer: a prospective phase II trial.Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma.Long-term outcome of concurrent chemoradiotherapy with elective nodal irradiation for inoperable esophageal cancer.Primary radio(chemo)therapy for esophageal cancer in elderly patients: are efficiency and toxicity comparable with younger patients?A Novel Prognostic Scoring System Using Inflammatory Response Biomarkers for Esophageal Squamous Cell Carcinoma.Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database.Radiotherapy Alone or Concurrent Chemoradiation for Esophageal Squamous Cell Carcinoma in Elderly Patients.A phase II study of S-1 with concurrent radiotherapy in elderly patients with esophageal cancer.What is the optimal radiation dose for non-operable esophageal cancer? Dissecting the evidence in a meta-analysis.Efficacy and safety of weekly nab-paclitaxel plus cisplatin with concurrent intensity-modulated radiotherapy in patients with inoperable, locally advanced esophageal cancer: a pilot trial
P2860
Q33571196-36E9E51B-A8BF-4696-A154-7870F04DB279Q33913820-C6A953AB-3665-461E-8BD7-6CCEF2C277F0Q37252364-61060E15-2B8C-4859-A561-CBF1771F5FF1Q37577939-763226BD-C96C-49E3-BAA6-DA8054518588Q37624523-84D516D2-241B-488B-90A5-02C74B125F32Q38700573-4ED7ADCB-F2E0-4FCA-9B9E-2C5B6FA4293CQ40959170-F2E29B04-EDBD-41B5-A912-2DE0DFA1081CQ47108241-739AA4C6-DA49-4FC5-9D44-33AC3E32DDBBQ47128205-DB771E32-D4A8-4FF1-8405-64C889A3084CQ47139282-2EF7F677-02AD-489D-9298-229493C2833DQ47140726-F8B0F8B2-A573-4A44-9D81-AADC8111C2D7Q47142547-CB753978-E893-459E-8D70-6F0BEF12C8F1Q57490416-49324265-FA30-431C-87F9-2187BC779036
P2860
Concurrent chemoradiotherapy using paclitaxel plus cisplatin in the treatment of elderly patients with esophageal cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Concurrent chemoradiotherapy u ...... tients with esophageal cancer.
@ast
Concurrent chemoradiotherapy u ...... tients with esophageal cancer.
@en
type
label
Concurrent chemoradiotherapy u ...... tients with esophageal cancer.
@ast
Concurrent chemoradiotherapy u ...... tients with esophageal cancer.
@en
prefLabel
Concurrent chemoradiotherapy u ...... tients with esophageal cancer.
@ast
Concurrent chemoradiotherapy u ...... tients with esophageal cancer.
@en
P2093
P2860
P356
P1476
Concurrent chemoradiotherapy u ...... tients with esophageal cancer.
@en
P2093
P2860
P304
P356
10.2147/OTT.S92537
P407
P577
2015-10-22T00:00:00Z